Introduction {#s1}
============

Infantile spasms (West syndrome) is an age-specific epileptic syndrome associated with many underlying conditions. It is often related to poor developmental outcomes, including severe cognitive dysfunction, brain damage, and mental regression [@pone.0045347-Lux1]. This disease responds poorly to nearly all traditional antiepileptic drugs, except adrenocorticotropic hormone (ACTH); however, the mechanisms of action of ACTH are still unclear. The conventional hypothesis states that ACTH modulates the expression and release of several neurotransmitters and neuromodulators by promoting glucocorticoid release, as well as by directly modulating amygdala neurons to decrease the proconvulsant peptide CRH [@pone.0045347-Brunson1]. The protective mechanism of ACTH against brain damage was investigated using two-dimensional electrophoresis (2DE) to analyze the proteomic changes following ACTH treatment in an animal model.

The *N*-methyl-[d]{.smallcaps}-aspartic acid (NMDA) model stimulates attacks in developing and young rats, causing rat hyperflexion seizures such as infantile spasms. However, ACTH has low efficiency in seizure models that involve non-stressed brains [@pone.0045347-Brunson1]--[@pone.0045347-Velisek1]. Using a case-control study, we found that the degree of prenatal stress (PS) is higher among mothers of infantile spasm patients than among those of the control group and that within a specific range, the risk of infantile spasms increases with the degree of PS [@pone.0045347-Shang1]. Animal studies have shown that PS significant affects the subsequent physical and mental health of the offspring and it plays an important role in increasing seizure vulnerability [@pone.0045347-Edwards1]. Therefore, we hypothesized that prenatal stress exposure improves the effectiveness of ACTH in our model. Pregnant rats were forced to swim in cold water to induce PS [@pone.0045347-Deutsch1]. The severity of their spasms was assessed, and the effectiveness of ACTH therapy was evaluated.

Results {#s2}
=======

Animal Model {#s2a}
------------

All NMDA-treated rats exhibited a well-defined behavioral pattern characterized by shortness of breath, irregular and dull eyes, a slight facial muscle twitch, shaking of the jaw, shaking of the head, frequent flicking of the tail, twisting of the body, moving around/irritability, biting other animals, and a high degree of paroxysmal spasms. Rat behavior was observed over time. The severity of the spasms in the animal models was assessed using spasm frequency and spasm latency ([Table 1](#pone-0045347-t001){ref-type="table"}).

10.1371/journal.pone.0045347.t001

###### Degree of spasm in the animal models.

![](pone.0045347.t001){#pone-0045347-t001-1}

  Group                                                 Spasm frequency (n)   Spasm latency (min)
  ---------------------------------------------------- --------------------- ---------------------
  A1 PS-spasm model-ACTH treatment                             23±5                  29±6
  A2 PS-spasm model[\*](#nt101){ref-type="table-fn"}           33±5                  17±3
  B1 spasm model-ACTH treatment                                24±5                  30±4
  B2 spasm model                                               22±2                  21±3
  B3 control                                                    --                    --

14 rats died from spasm.

Compared with the spasm model ([Figure 1](#pone-0045347-g001){ref-type="fig"}), the PS-spasm model exhibited an increased spasm frequency (t = 8.65, *P*\<0.001) and a shorter latency period (t = 3.96, *P*\<0.001). ACTH treatment was effective in the PS-spasm model, which exhibited a lower spasm frequency (t = 5.75, *P*\<0.001) and longer latency period (t = 6.9, *P*\<0.001). However, the spasm models did not show obvious responses to ACTH treatment; the latency period was longer (t = 7.3, *P*\<0.001), but no improvement was observed in spasm frequency (t = 1.4, *P* = 0.16). Based on these results, we concluded that maternal stress during pregnancy results in a higher number of severe seizures in the animal models. ACTH treatment reduced onset, which suggests a response to ACTH treatment.

![Severity of spasm in the animal models.\
(a) spasm frequency, (b) spasm latency. Group A1, prenatal stress (PS)-spasm model-ACTH treatment; Group A2, PS-spasm model; Group B1, spasm model-ACTH treatment; and Group B2, spasm model. The PS-spasm model (Group A2 vs. Group B2) showed an increased spasm frequency (t = 8.65, *P\<*0.001) and a shortened latency period (t = 3.96, *P*\<0.001). ACTH treatment was effective in treating the PS-spasm model (Group A1 vs. Group A2) and shows a lower spasm frequency (t = 5.75, *P*\<0.001) and a lengthened latency period (t = 6.9, *P*\<0.001). The spasm models showed no obvious response to ACTH treatment (Group B1 vs. Group B2), but a lengthened latency period was observed (t = 7.3, *P*\<0.001). Spasm frequency was not significantly different among the models (t = 1.4, *P* = 0.16).](pone.0045347.g001){#pone-0045347-g001}

2DE Analysis {#s2b}
------------

Based on the 2DE maps that contained 46 spots, a ±1.5-fold difference was observed in the prenatal stress-spasm model-ACTH treatment (Group A1) compared with the PS-spasm model (Group A2). A total of 10 protein spots represented up-regulated proteins, whereas 36 represented down-regulated proteins.

Eight differentially expressed proteins were identified. These proteins are shown in [Figure 2](#pone-0045347-g002){ref-type="fig"} and their identification results are in [Table 2](#pone-0045347-t002){ref-type="table"}. The differentially expressed proteins are involved in various biological functions, including cytoskeletal rearrangement (tubulin α-1A chain, isoform 1 of tubulin β-5 chain, n-cofilin \[CFL1\]), neuroprotection (*N*(G),*N*(G)-dimethylarginine dimethylaminohydrolase \[Ddah1\], synaptosomal-associated protein 25 \[SNAP-25\]), and metabolism (malate dehydrogenase \[Mdh1\], rho GDP-dissociation inhibitor 1 \[ARHGDIA\]).

![2DE map of the rat brain from Groups A1 and A2 stained with CBB.\
The gels were loaded with 1 mg of protein, run on 24 cm pH 3--10 NL IPG, and separated using 12% SDS-PAGE. Numbered protein spots were identified.](pone.0045347.g002){#pone-0045347-g002}

10.1371/journal.pone.0045347.t002

###### Significantly differentially expressed proteins identified from rat brain samples using MALDI-TOF/TOF-MS.

![](pone.0045347.t002){#pone-0045347-t002-2}

  Rank                                              Symbol/Description                       Accession No.     Mr      pI    Score   Pep. Count   Fold Change
  ----------------------------- ----------------------------------------------------------- --------------- -------- ------ ------- ------------ -------------
  **Up-regulated proteins**                                                                                                                      
  1                                      Snap25/Synaptosomal-associated protein 25            IPI00204644    129676   9.39    71         18          2.81
  2                                      Tubb5/Isoform 1 of the Tubulin β-5 chain             IPI00197579    49639    4.78    97         10          2.74
  3                                                  Anxa3/Annexin A3                         IPI00207390    36341    5.96    225        16          2.56
  4                                       Mdh1/Malate dehydrogenase, cytoplasmic              IPI00198717    36460    6.16    151        12          1.76
  5                              Ddah1/N(G),N(G)-dimethylarginine dimethylaminohydrolase 1    IPI00231194    31406    5.75    153        17          1.75
  6                                                   Cfl1/Cofilin-1                          IPI00327144    18521    8.22    77         14          1.56
  7                                      Arhgdia/Rho GDP-dissociation inhibitor 1             IPI00196994    23393    5.12    182        11          1.53
  **Down-regulated proteins**                                                                                                                    
  8                                              Tuba1a/Tubulin α-1A chain                    IPI00189795    50104    4.94    98         17          0.48

Validation of Differential Expression by Western Blot {#s2c}
-----------------------------------------------------

We performed western blot analysis to verify the differential expression between Group A1 (PS-spasm model-ACTH treatment) and Group A2 (PS-spasm model) ([Figure 3a](#pone-0045347-g003){ref-type="fig"}). Western blot analyses indicated that annexin A3 (ANXA3), ARHGDIA, and CFL1 were up-regulated in Group A1 ([Figure 3b](#pone-0045347-g003){ref-type="fig"}). The results are consistent with those of the 2DE ([Figure 3c](#pone-0045347-g003){ref-type="fig"}).

![Increased expression of ANXA3, ARHGDIA, and CFL1 in the PS-spasm model-ACTH treatment (Group A1).\
(a) The proteins were analyzed using 12% (SDS--PAGE) and western blot analysis. GAPDH was used for normalization. (b) The intensities of ANXA3, ARHGDIA, and CFL1 expression from the immunoblots are shown in (a), as quantified using densitometric analysis. (c) The spots of ANXA3, ARHGDIA, and CFL1 are marked by arrows on the 2DE gel.](pone.0045347.g003){#pone-0045347-g003}

Functional Analysis {#s2d}
-------------------

According to gene ontology (GO) analysis, the differentially expressed proteins are involved in protein polymerization, microtubule-based movement, and cellular protein complex assembly, with the functional keywords 'acetylation,' 'microtubule,' and 'cytoplasm' ([Table 3](#pone-0045347-t003){ref-type="table"}). The Cytoscape software was used to construct protein networks. The identified proteins formed three functional modules based on protein--protein interactions ([Figure 4](#pone-0045347-g004){ref-type="fig"}). The differentially expressed proteins SNAP-25 and Tuba1a were connected by the proteins caveolin-1 (CAV1) and dynamin-2 (DNM2).

10.1371/journal.pone.0045347.t003

###### GO analysis and protein functional keyword analysis.

![](pone.0045347.t003){#pone-0045347-t003-3}

  GO Term                                           PValue                      Genes                       Fold Enrichment
  ---------------------------------------------- ------------ ------------------------------------------ ---------------------
  GO:0051258∼protein polymerization               0.01753637                TUBB5, TUBA1A                     97.05714286
  GO:0007018∼microtubule-based movement           0.0437855                 TUBB5, TUBA1A                     38.43847242
  GO:0043623∼cellular protein complex assembly    0.04675995                TUBB5, TUBA1A                     35.94708995
  **key words**                                   **PValue**                  **Genes**                   **Fold Enrichment**
  acetylation                                      6.23E-04    CFL1, TUBB5, DDAH1, ANXA3, ARHGDIA, MDH1       5.759354839
  microtubule                                     0.08350872                TUBB5, TUBA1A                     20.19683258
  cytoplasm                                       0.09998266         CFL1, SNAP25, ARHGDIA, MDH1              2.947177286

![Biological function network map of the differentially expressed proteins.\
The red diamonds represent up-regulated proteins, green diamonds represent down-regulated proteins, pink circles represent proteins that interact with the differentially expressed proteins, and the lines represent relationships.](pone.0045347.g004){#pone-0045347-g004}

ARHGDIA Expression in Epileptic Foci of Infantile Spasm Patients {#s2e}
----------------------------------------------------------------

[Figure 5](#pone-0045347-g005){ref-type="fig"} shows ARHGDIA expression in five cases with epileptic foci in the brain. Comparison between patients P1 and P2 who were treated with ACTH and patients P3 to P5 suggests that ARHGDIA expression was more pronounced (no statistical analysis was performed due to the small sample size) in P1 and P2, particularly in P2 who responded to the ACTH treatment. Arrow: Possible ARHGDIA expression in the nucleus.

![Immunohistochemical staining of ARHGDIA visualized by brown signals in the epileptogenic foci of brain tissue.\
P1--P5 are the patient IDs. P1 and P2: patients with ACTH treatment, P3--P5: patients without ACTH treatment. From the figure, ARHGDIA expression was more pronounced (no statistical analysis was performed due to the small sample size) in P1 and P2, particularly in P2 who responded to the ACTH treatment. Arrow: possible ARHGDIA expression in the nucleus.](pone.0045347.g005){#pone-0045347-g005}

Discussion {#s3}
==========

Based on clinical epidemiology, PS affects offspring health. Animal studies have clearly demonstrated the effects of PS on the brains of offspring [@pone.0045347-VandenHove1]. In our previous study, the incidence of infantile spasms was related to prenatal distress [@pone.0045347-Shang1]. Our research showed that the spasm frequency did not differ between groups B1 and B2, although the spasm latency period in group B1 was longer than that in group B2. This result implies that NMDA-induced spasms are not sensitive to acute pretreatment with glucocorticoids, which is consistent with other reports [@pone.0045347-Velisek1]. We found that maternal stress during pregnancy results in more severe NMDA-induced seizures in the offspring. Furthermore, ACTH treatment reduces and delays the onset of these seizures, which correlates well with the treatment of infantile spasm with ACTH therapy. PS exposure damages the hippocampal neurons and the neuronal ultrastructure of the offspring and alters neurotransmitter receptor expression. Deutsch reported that the dose-related capability of MK-801 to increase the threshold voltage necessary for eliciting tonic hindlimb extension in mice is reduced 24 h after stress (swimming in cold water) [@pone.0045347-Deutsch1]. MK-801 is a noncompetitive NMDA receptor antagonist whose action depends on the open configuration of the channel and its interaction with the hydrophobic domain within the ligand-gated ion channel. This finding suggests that stress does not reduce the number of activated or open channels [@pone.0045347-Deutsch2].

We analyzed differentially expressed proteins between the PS-spasm model-ACTH treatment and the PS-spasm model using proteomics technology. Eight significantly differentially expressed proteins were identified, with biological functions related to the cytoskeleton, synapses, energy metabolism, vascular regulation, and signal transduction.

Cytoskeleton {#s3a}
------------

Spot 8, which represents the tubulin α-1A chain, was down-regulated, whereas Spot 2, the isoform 1 of tubulin β-5 chain, and spot 6, CFL1, were up-regulated. Consistent with our results, in a prior study on temporal lobe epilepsy in an animal model and in patients, cytoskeleton proteins significantly changed, which implies that the cytoskeleton is associated with the pathogenesis of epilepsy. The cytoskeletal structure is complex and serves to control cellular shape, membrane protein distribution, control of intracellular trafficking mechanisms, and generation and motility of growth cones, spines, and dendrites [@pone.0045347-Liu1]. Tubulin α 1A mutations are associated with type I lissencephaly and are subsequently found in children with mental retardation and brain malformations and exhibit a wide spectrum of severities [@pone.0045347-FalletBianco1]--[@pone.0045347-Jaglin1]. Type I lissencephaly is significantly correlated with infantile spasms, with infantile spasms occurring in more than 90% of type I lissencephaly cases [@pone.0045347-Guerrini1]--[@pone.0045347-Kato1]. Greene et al. reported that the tubulin α-1A chain is up-regulated in pilocarpine-induced temporal lobe epilepsy based on proteomics analysis [@pone.0045347-Greene1]. These findings imply that the change in tubulin α-1A chain is related to ACTH treatment.

Cofilins are actin-binding proteins that disassemble actin filaments. They are widely distributed in various tissues. Three actin-depolymerizing factors (CFL1, m-cofilin, and actin depolymerization factor) are found in mice and humans. CFL1 is distributed in non-muscle tissue, particularly in the brain and the liver, and is associated with neuronal migration disorders and cell cycle control in the cerebral cortex. Many neuronal disorders, such as lissencephaly, epilepsy, and schizophrenia, are caused by the abnormal migration of neurons in the developing brain. The main defects observed in CFL1 mutant embryos include impaired delamination and migration of neural crest cells, which affect the development of neural crest-derived tissues [@pone.0045347-Bellenchi1]. CFL1 knockout mice exhibit failure of neural tube closure and die *in utero* [@pone.0045347-Gurniak1]. In our study, CFL1 up-regulation in the ACTH treatment group suggests that ACTH improves neuronal migration.

Synaptic Proteins {#s3b}
-----------------

Spot 1, which corresponds to SNAP-25, was up-regulated. SNAP-25 is a plasma membrane protein that, together with syntaxin and the synaptic vesicle protein VAMP/synaptobrevin, forms the soluble *N*-ethylmaleimide--sensitive factor attachment protein receptor docking complex that regulates exocytosis. SNAP-25 also modulates different voltage-gated calcium channels. Recent genetic studies in humans and some mouse models indicate that alterations in the SNAP-25 gene structure, expression, and/or function directly contribute to these distinct neuropsychiatric and neurological disorders [@pone.0045347-Corradini1]. SNAP-25 stimulates γ-aminobutyric acid (GABA) release during development and it is expressed in the synaptic anterior of mature GABA neurons, involved in neurotransmission, and closely related with epilepsy [@pone.0045347-Tafoya1]. SNAP-25 is down-regulated in temporal lobe epilepsy animal models and in patients by proteomic analysis, which implies synaptosome dysfunction [@pone.0045347-Liu1]. In the present study, SNAP-25 up-regulation suggests the neuroprotective function of ACTH.

Energy Metabolism {#s3c}
-----------------

Spot 4, which corresponds to Mdh1, was up-regulated. Mdh1 is a key enzyme in glucose metabolism that catalyzes the reversible conversion of malate into oxaloacetate and plays an important role in various physical cellular activities, such as mitochondrial energy metabolism. Impaired cellular energy metabolism affects brain injury. The role of mitochondrial energy metabolism in excitotoxic perinatal brain injury was assessed by examining the toxicity of aminooxyacetic acid, a mitochondrial malate-aspartate shunt inhibitor. Previous studies suggest that regional impairment of cellular energy metabolism is an important determinant of selective vulnerability to the brain injury induced by NMDA in perinatal rats [@pone.0045347-McDonald1]. Mitochondrial function is a key determinant of neuronal excitability and viability of neurons in a study that examined the chronic generalized seizures induced by picrotoxin in rats. Mdh1 was decreased by 20% to 80% [@pone.0045347-Acharya1]. The function of cytosolic Mdh1 was analyzed using RNA interference. The *in vitro* oocyte maturation rate was significantly decreased by 34%, and the rate of blastocyst development was 48.1%, which was significantly lower than that in the control. The results indicate that Mdh1 is an essential factor for oocyte maturation and embryo development in mice [@pone.0045347-Yoon1]. Therefore, Mdh1 plays an important role in both energy metabolism and embryonic development. In the ACTH-treatment group, Mdh1 up-regulation improves energy metabolism and the mechanism of ACTH function.

Vascular Regulation {#s3d}
-------------------

Spot 5, which corresponds to Ddah1, was up-regulated. This enzyme is primarily found in the cytoplasm. It is highly expressed in vascular endothelial cells and it plays an important role in vascular endothelial regulation. Ddah1 overexpression increases vascular nitric oxide levels and protects against hyperhomocysteinemia-induced alterations in cerebral arteriolar structure and vascular muscle function [@pone.0045347-Rodionov1]. Breckenridge examined transgenic Ddah1 knockout mice and found that homozygous Ddah1 null embryos are generated at a low frequency and do not progress through embryonic development. Furthermore, Ddah1 is involved in embryonic development, potentially through its specific effects on the nitric oxide pathways [@pone.0045347-Breckenridge1]. Ddah1 upregulation in the ACTH treatment group affects blood vessel stability and improves neuroprotection.

Signal Transduction {#s3e}
-------------------

Spot 3, which corresponds to ANXA3, was up-regulated. ANXA3 belongs to the lipocortin/annexin family, which bind to phospholipids and membranes in a calcium-dependent manner. Weitzdörfer reported that ANXA3 levels increase in the rat hippocampus at varying developmental time points, which implies that ANXA3 is related to brain development [@pone.0045347-Weitzdorfer1]. Chen examined the signaling protein levels in the hippocampus of voluntary and treadmill-exercised rats using a proteomics approach and reported that ANXA3 expression significantly differs under these conditions, which suggests that ANXA3 is involved in signal transduction in hippocampal neurons [@pone.0045347-Chen1]. Therefore, ACTH treatment is related to brain development and signal transduction.

Spot 7, which represents ARHGDIA, was up-regulated. ARHGDIA belongs to the ras gene superfamily and it is distributed throughout all tissues. Its biological activities include anti-apoptosis, cell movement, negative regulation of cell adhesion, and rho protein signal transduction, among others. ARHGDIA is also associated with neural development and the growth of axons and dendrites. ARHGDIA gene knockout mice showed cognitive deficits, including short-term memory defects, lowered aggression, and altered social behavior. Furthermore, ARHGDIA preferentially impairs the forebrain functions required to form temporal associations, which is similar to mental retardation in humans [@pone.0045347-Chelly1]. Curie performed a neuropsychological and imaging study on patients with mutations in the ARHGDIA gene. Voxel-based morphometric analysis revealed significant changes, mainly in the cerebello-thalamo-prefrontal pathway, in the brain MRIs of patients with ARHGDIA mutations compared with those from normal subjects [@pone.0045347-Curie1]. The results of the animal models and patient studies suggest that ARHGDIA disorders disrupt the neuronal function. ARHGDIA up-regulation in the ACTH-treatment group suggests that it exerts neuroprotective effects. Hence, we performed a preliminary study on ARHGDIA expression in brain samples from a small but valuable sample of five infantile spasm patients and found differential expression. In the epilepsy foci study of human specimens, our data indicates a similar trend, although the number of samples was limited, i.e., the ARHGDIA expression levels in the ACTH treatment group (P1, P2) were higher than those in the non-treatment group (P3 to P5). In particular, ARHGDIA expression was high in P2, who responded well to treatment. ACTH is the only drug treatment for which long-term infantile spasms outcomes are available. Patients treated early with ACTH had favorable long-term prognoses [@pone.0045347-Stafstrom1]. In this study, differential ARHGDIA expression was related to ACTH treatment, which indicates that ACTH enhances ARHGDIA expression. However, this study has some limitations. First, a very limited number of samples were studied because of the difficulty in obtaining human specimens because very few infantile spasm patients opt for surgical treatment in China. The five cases underwent the operation because of obvious intracranial lesions and intractable seizures, which do not reflect well in the cryptogenic infantile spasms. Furthermore, no normal human control specimens are available. The specimens comprised epileptic foci from differential lobes (P1, occipital lobe; P2, parietal lobe; P3, parietal lobe; P4, temporal lobe; P5, temporal lobe). Hence, the results are preliminary and further studies will be performed when more samples are obtained.

Using GO analysis, we also found that differentially expressed proteins are involved in protein polymerization, microtubule-based movement, and cellular protein complex assembly. As described above, cytoskeletal stability is closely associated with epilepsy. We found that SNAP-25 and TUBA1A are related through CAV1 and DNM2 by establishing a biological regulatory module. SNAP-25 and CAV1 are present in neurons and colocalize in axonal varicosities. A short-term SNAP-25--CAV1 interaction is possibly involved in the early phase of synaptic potentiation [@pone.0045347-Braun1]. CAV1 is a scaffolding protein for Src kinase and other components of the endocytic machinery. Src-induced DNM2 phosphorylation is necessary for caveolae release [@pone.0045347-Shajahan1]. DNM2 is a member of one of the GTP-binding protein subfamilies, and it binds many proteins that bind to actin and other cytoskeletal proteins. DNM2 also stimulates GTPase activity. These results suggest that SNAP-25 interacts with Tuba1a, which involves neurotransmitter transmission, synaptic reconstruction, and so on.

We also found many differentially expressed proteins (75%, 6/8) associated with the biological function of acetylation in the present study, which indicating that the ACTH treatment mechanism involves the protein acetylation pathway. Protein acetylation regulates a wide range of cellular functions in eukaryotes, particularly via transcriptional control in the nucleus, such as transcription, proliferation, apoptosis, and differentiation. Recently, acetylation was reported to play a significant role in the regulation of metabolic enzymes, metabolic pathways, and metabolic enzyme activity [@pone.0045347-Wang1]. Deutsch reported that inducing stress in mice (forced swimming in cold water) reduces the antiseizure efficacy of MK-801, which is reversed by sodium butyrate, a histone deacetylase inhibitor that typically promotes gene expression. Sodium butyrate also increases the acetylation of H3 and H4 histone proteins in the hippocampus and the cerebral cortex of mice [@pone.0045347-Schroeder1]. These data suggest that protein acetylation can be used to develop epigenetic strategies.

In summary, the differentially expressed proteins include those involved in the cytoskeleton, synapses, energy metabolism, vascular regulation, and signal transduction, which confirm the hypothesis that ACTH modulates the expression and release of several neurotransmitters and neuromodulators. The onset of infantile spasms is age-specific and can be caused by many factors. Cortical malformation during development is one of these important factors. The differentially expressed proteins CFL1, ANXA3, and ARHGDIA are all closely related to brain development, which implies that ACTH therapy promotes brain maturation. The differentially expressed proteins are associated with acetylation, which can be used to develop a therapeutic strategy for treating IS.

Materials and Methods {#s4}
=====================

Ethical Statement {#s4a}
-----------------

The experimental procedures and the animal use and care protocols were approved by the Institutional Animal Care and Use Committee of the General Hospital of the Chinese People\'s Liberation Army (Approval ID no. 2008B079).

10.1371/journal.pone.0045347.t004

###### Clinical characteristics of patients.

![](pone.0045347.t004){#pone-0045347-t004-4}

  ID    Sex    Age                        MRI                                                                            ACTH treatment                                                       Antiepileptic drugs                             Operation
  ---- ----- ------- ---------------------------------------------- ------------------------------------------------------------------------------------------------------------------------ --------------------- ----------------------------------------------------------------
  P1     F    16 mo    abnormal signal in the left occipital lobe                         ACTH 20 U/day for 20 days by vein injection Six months ago with no response                              VAP, TOP                 resection of the left occipital epileptic foci
  P2     M    14 mo    abnormal signal in the left parietal lobe     ACTH 20 U/day for 16 days by vein injection Seven months ago, seizure-free, but relapsed 19 days after ACTH withdrawal           VAP                   resection of the left parietal epileptic foci
  P3     M    16 mo   a large area of the right hemisphere malacia                                                             --                                                                  TOP, LEV                       resection of the right hemisphere
  P4     M     4 y      cerebromalacia in the left temporal lobe                                                               --                                                                NZP, TOP, LEV      resection of brain malacia and incision of the corpus callosum
  P5     F     3 y       pachygyria of the right occipital lobe                                                                --                                                                  CZP, LAM,               resection of the right occipital epileptic foci

LAM, Lamotrigine; LEV, Levetiracetam; SVP, Sodium Valproate; TOP, Topiramate; CZP, Clonazepam; NZP, Nitrazepam.

Animal and Spasm Models {#s4b}
-----------------------

Three-month-old Wistar rats (weight: 275 g to 345 g, 31 females, 10 males, obtained from the Experimental Animal Center, Capital Medical University) were used in the study. The animals were maintained on a 12 h light/dark cycle with food and water available ad libitum. The female Wistar rats were mated with stud males and the time of appearance of a vaginal plug was considered gestational day 1. The pregnant rats were randomly divided into two groups: Group A, prenatal stress (PS); and Group B, non-prenatal stress. In Group A, the pregnant rats were subjected to physical stress consisting of forced immersion in 4°C water in Plexiglas cylinders. The water was approximately 35 cm deep, so the rats could not stand up without touching the bottom of the cylinder with their tails. After 5 min in the water, the rats were removed and dried for 10 min in a heated container before they were returned to their home cages. The stress was administered daily at 17:00 from day 1 of pregnancy until parturition. Their postnatal 13-day-old pups were randomly divided into two subgroups (n = 15): Group A1, the PS-spasm model-ACTH treatment; and Group A2, the PS-spasm model. In Group A1, the pups were treated with natural, animal-derived ACTH (20 IU/kg, Shanghai Pharmaceutical Co., Ltd., China) by intraperitoneal (i.p.) injection, and were administered NMDA (7 mg/kg, i.p.) after 30 min. In Group A2, the pups were treated with saline, and were administered NMDA (7 mg/kg, i.p.) after 30 min. In Group B, the pregnant rats were not exposed to stress. Their postnatal 13-day-old pups were randomly divided into three subgroups (n = 15): Group B1, the spasm model-ACTH treatment; Group B2, the spasm model; and Group B3, the control. The B1 and B2 pups were administered the same treatment as Groups A1 and A2, respectively. In Group B3, the pups were administered saline (i.p.) as the control. The behaviors of each group were observed continuously for 3 h. High degree of flexion (head and trunk flexion, forelimb, hind limb, and hip flexion) was defined as the onset of spasms. We recorded the latency (after i.p. NMDA administration) to the onset of spasms and the total number of spasms to assess the severity of the spasms.

Sample Preparation {#s4c}
------------------

The brains of five randomly selected rats from each group were removed after decapitation, immediately frozen in liquid nitrogen, and ground into powder. Lysis buffer was added (100 mg in 500 µL) before the addition of 500 µL of protease inhibitors. This was followed by dissolution for 1 h, sonication (4 s/time, 200 W, 12 s intervals), addition of Dnase I and Rnase A, incubation at 4°C, and centrifugation at 40,000×*g* for 1 h. Protein sample quality was then determined using the Coommassie Brilliant Blue (CBB) staining method.

Two-dimensional Gel Electrophoresis {#s4d}
-----------------------------------

2DE was performed as reported [@pone.0045347-Wang2]. Briefly, 1 mg of the protein samples were diluted in rehydration solution (7 M urea, 4% CHAPS detergent, 0.5% IPG buffer v/v, 60 mM DTT) to a final volume of 450 µL and were applied to immobilized pH 3--10 nonlinear gradient (IPG) strips (GE Healthcare, formerly Amersham Biosciences, Uppsala, Sweden) for 16 h. Isoelectric focusing (IEF) analysis was performed using an IPGphor IEF System (GE Healthcare) at 17°C with the following voltage program: 200 V (step and hold for 1 h), 500 V (step and hold for 1 h), 1000 V (step and hold for 1 h), and 8000 V (gradient, total 60 kV•h). Prior to the second-dimensional gel separation, the IPG strips were equilibrated twice for 12 min with gentle shaking in 10 mL of equilibration buffer containing 50 mM Tris-Cl (pH 8.8), 6 M urea, 20% v/v glycerol, and 2% SDS. DTT (1%) was then added to the first equilibration step and 4% iodoacetamide was added to the second equilibration step. Second-dimensional separation (Ettan TMDALT SIX, GE Healthcare) was performed using 12% SDS polyacrylamide gels. The gels were run at 15 mA per gel for 30 min, followed by 30 mA per gel until the bromophenol blue reached the bottom of the gel. The gels were scanned using an Image Scanner (GE Healthcare). Gel analysis of the gels to compare protein content between different samples was performed using Image Master 2-D Platinum software (Amersham Biosciences). Statistical analysis was conducted using SPSS software (Version 13.0, SPSS).

Mass Spectrometry (MS) Analysis {#s4e}
-------------------------------

The protein spots of interests were excised from the CBB-stained gel and were destained in 100 µL of 50 mM ammonium bicarbonate containing 30% CAN for 16 h. The solution was discarded to remove the CBB dye. The dye-washing step was repeated several times until the CBB staining was completely removed. The gel pieces were dehydrated in a SpeedVac evaporator. For trypsin digestion, the gel pieces were rehydrated in 8 µL of trypsin solution, and 25 mM NH~4~HCO~3~ was added until the solution was completely absorbed by the gel. The solution was incubated overnight at 37°C. Then, 100 µL of 5% trifluoroacetic acid (TFA) was added to the dissolved gel pieces, incubated at 37°C for 1 h, and sonicated for 5 min. The suspension was collected and incubated at 37°C for 1 h after the addition of 50% acetonitrile and 2.5% TFA, followed with further sonication for 5 min. The suspension was collected and allowed to dry completely. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS/MS) measurement of the spotted peptide solutions was conducted using an ABI 4800 Proteomics Analyzer (Applied Biosystems, Foster City, CA). The spectra were recorded in reflector mode at a molecular mass range of 900 Da to 3500 Da, with a focus mass of 2000 Da. An International Protein Index (IPI) database search of MS and MS/MS measurements was performed using GPS Explorer software (Applied Biosystems). The peak lists were restricted to Rattus taxonomy, an ms/ms fragment of 0.3 Da, and precursor tolerance of 0.2 Da. A total score over 67 was defined as positive.

Western Blot Analysis {#s4f}
---------------------

Protein quantifications of ANXA3, ARHGDIA, and CFL1 were validated using western blot analysis. GAPDH was used as the internal control. A total of 50 µg of the total protein samples was fractionated using electrophoresis through 15% polyacrylamide gels and transferred to a polyvinylidene difluoride membrane (GE Healthcare) following the manufacturer's instructions. The membrane was probed with the primary antibody, mouse-derived anti-GAPDH antibodies (1∶500 in TBST, Beijing Zhongshan Biotechnology, Zhongshan, China), or rabbit-derived anti-ANXA3 (Bioworld Consulting Laboratories, LLC, Mt. Airy, MD), anti-ARHGDIA (Proteintech, Chicago, IL), and anti-CFL1 (Bioworld) antibodies (1∶500 in TBST) for 1.5 h at room temperature. Then, the membrane was incubated with the HRP-conjugated goat anti-mouse or anti-rabbit secondary antibodies (1∶5000 in TBS-T, Beijing Zhongshan Biotechnology), and incubation at room temperature for 1 h. Chemiluminescence substrate luminal reagent (GE Healthcare) and exposure to X-ray film were used to identify the immunolabeled bands. The optical density of the bands was scanned and was quantified using the Image J program.

Bioinformatics Analysis {#s4g}
-----------------------

GO analysis and protein functional keyword analysis were performed using DAVID tools based on Fisher's exact test for GO term enrichment [@pone.0045347-Huangda1]. KEGG (Kyoto Encyclopedia of Genes and Genomes) [@pone.0045347-Kanehisa1] pathway enrichment analysis was performed using DAVID tools. The *P*-values of the differentially expressed proteins were calculated using the hypergeometric statistical test method and were mapped to the pathway. A *P*-value cut-off of 0.05 was considered significant. The protein interaction networks of the differentially expressed proteins were established based on the Cytoscape platform by searching a public protein--protein interaction database [@pone.0045347-Cline1].

Patients {#s4h}
--------

This study was approved by the Institutional Review Board. The paraffin-embedded tissues of five patients were obtained from the Epilepsy Surgery Center of Tsinghua University Yuquan Hospital between 2007 and 2009 ([Table 4](#pone-0045347-t004){ref-type="table"}). All patients were drug-resistant and their imaging findings showed lesions. The decision for surgery was based on the convergent evidence of clinical and electroencephalogram (EEG) recordings and magnetic resonance imaging (MRI) findings. The surgical specimens were analyzed using routine histopathologic examination. The clinical information of the infantile spasm patients is presented in [Table 1](#pone-0045347-t001){ref-type="table"}. Patients P1 and P2 received ACTH treatment. P2 was seizure-free and showed good response to ACTH, but relapsed 19 d after drug withdrawal.

Immunohistochemistry {#s4i}
--------------------

The surgical specimens were fixed in formalin via the routine procedure, embedded in paraffin, and cut into 8 mm sections. Then, the sections were deparaffinized, immersed in 3% H~2~O~2~ in darkness for 15 min, and rinsed thoroughly in PBS. The sections were placed in a microwave oven for 20 min in sodium citrate, cooled at room temperature, and blocked with 10% normal goat serum for 12 min. After incubation with primary antibodies, the sections were incubated overnight with anti-ARHGDIA (1∶100) at 4°C. Finally, the sections were incubated with rabbit anti-human IgG and treated with avidin--biotin peroxidase complex for color development. A 3,30-diaminobenzidine kit was used as the chromogen, and the sections were dehydrated in alcohol, washed with xylene, and mounted using gum.
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